Differential expression analysis of serum exosome miRNAs in acral melanocytic tumor
Liquid biopsy candidates in blood exosomes could offer non-invasive ways to distinguish acral melanoma from harmless skin growths.
Serum exosome miRNA sequencing in acral melanocytic tumor patients identified 69 differentially expressed miRNAs enriched in cancer and MAPK pathways, proposing a panel of non-invasive liquid biopsy candidates for distinguishing acral melanoma from benign nevi. Sample size was not reported in the abstract, limiting interpretation.
What the study was
- Study design
- Exploratory biomarker study (miRNA sequencing)
- Population
- Patients with acral melanocytic tumors (nevus vs acral melanoma)
- Category
- Early Detection
- Maturity
- Exploratory
- Journal
- Pakistan Journal of Pharmaceutical Sciences
Why it surfaced
Acral melanoma is underrepresented in liquid biopsy research; exosomal miRNA profiling is promising approach; sample size unstated in abstract lowers confidence.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.